SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in Bone Biologics

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 9.99% beneficial ownership stake in Bone Biologics Corporation as of September 30, 2025.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (the "Reporting Persons") collectively reported beneficial ownership of 199,251 shares of Bone Biologics Corporation common stock.
• This ownership represents approximately 9.99% of the company's common stock, calculated based on 1,795,260 shares outstanding as of August 14, 2025, plus the 199,251 shares issuable from one warrant.
• The shares are issuable upon the exercise of Intracoastal Warrant 1, held by Intracoastal Capital LLC.
• The Reporting Persons also hold additional warrants (Intracoastal Warrants 2-6) that contain blocker provisions, preventing exercise if it would result in beneficial ownership exceeding 9.99% or 4.99%, depending on the specific warrant.
• Without these blocker provisions, the Reporting Persons would have beneficial ownership of 571,294 shares of Common Stock.

Sentiment

Score: 6

Explanation: The disclosure of a 9.99% beneficial ownership stake by a group of investors, including an investment firm, indicates a notable commitment to Bone Biologics Corporation. While the blocker provisions limit immediate full exercise of all warrants, the overall holding suggests continued investor interest.

Positives

• A significant beneficial ownership stake of 9.99% by Intracoastal Capital and its principals indicates a notable investment and potential confidence in Bone Biologics Corporation.
• The continued holding of warrants suggests a long-term interest in the company's future performance.

Negatives

• The presence of blocker provisions on multiple warrants limits the immediate ability of the Reporting Persons to increase their voting power beyond the stated percentages, potentially capping their influence.
• The inability to fully exercise all warrants due to these blockers means a substantial portion of potential shares (571,294 total vs. 199,251 currently counted) is not yet reflected in the beneficial ownership percentage.

Risks

• The blocker provisions on the warrants could limit the Reporting Persons' ability to fully capitalize on their investment if the share price increases significantly, as they cannot exceed certain ownership thresholds.
• The existence of multiple warrants with varying blocker thresholds (9.99% and 4.99%) adds complexity to the ownership structure and potential future exercises.

Stakeholder Impact

• Shareholders: The disclosure of a significant ownership stake by a group of investors could be viewed positively, signaling confidence in the company. However, the blocker provisions might limit the potential for these investors to exert greater influence or fully realize their investment through warrant exercise.

Key Dates

Keywords

Bone Biologics Corporation, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, beneficial ownership, common stock, warrants, equity stake, institutional investor